Harmony Biosciences Holdings (HRMY) Treasury Shares (2019 - 2026)
Harmony Biosciences Holdings (HRMY) reported Treasury Shares of $1.0 million for Q1 2026, up 11.08% on a YoY basis from $944252.0 in Q1 2025, and up 31.69% sequentially from $796498.0 in Q4 2025.
Harmony Biosciences Holdings (HRMY) Treasury Shares (2019 - 2026) Analysis & Trends
Harmony Biosciences Holdings (HRMY) has 8 years of Treasury Shares data on file, last reported at $1.0 million in Q1 2026.
- For the quarter ending Q1 2026, Treasury Shares rose 11.08% year-over-year to $1.0 million; the trailing twelve-month figure through Mar 2026 stood at $1.0 million (up 11.08% YoY), and the FY2025 full-year result was $796498.0, up 24.67% from the prior year.
- Treasury Shares advanced to $1.0 million in Q1 2026, from $796498.0 in the prior quarter.
- In the past five years, Treasury Shares ranged from a high of $1.0 million in Q1 2026 to a low of $43208.0 in Q1 2023.
- A 5-year average of $464702.4 and a median of $638900.0 in 2024 frame the typical range for Treasury Shares.
- Across the five-year window, Treasury Shares declined 27.99% in 2023 and soared 1696.77% in 2024, its largest moves.
- Tracing HRMY's Treasury Shares over 5 years: stood at $60000.0 in 2022, then soared by 450.0% to $330000.0 in 2023, then surged by 93.61% to $638900.0 in 2024, then advanced by 24.67% to $796498.0 in 2025, then jumped by 31.69% to $1.0 million in 2026.
- Business Quant data shows HRMY's Treasury Shares at $1.0 million in Q1 2026, $796498.0 in Q4 2025, and $799587.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -21,709.08 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 265,401.92 |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 19.41 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 5.14 Mn |
| 10 | Harmony Biosciences Holdings | 2.07 Bn | 1.55 Bn | 170.88 Mn | 1.05 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.05 Mn |
| Mar 31, 2026 | 1.05 Mn |
| Dec 31, 2025 | 796,498.00 |
| Dec 31, 2025 | 796,498.00 |
| Sep 30, 2025 | 799,587.00 |
| Sep 30, 2025 | 799,587.00 |
| Jun 30, 2025 | 847,264.00 |
| Jun 30, 2025 | 847,264.00 |
| Mar 31, 2025 | 944,252.00 |
| Mar 31, 2025 | 944,252.00 |
| Dec 31, 2024 | 638,900.00 |
| Dec 31, 2024 | 638,900.00 |
| Sep 30, 2024 | 646,400.00 |
| Sep 30, 2024 | 646,400.00 |
| Jun 30, 2024 | 776,350.00 |
| Jun 30, 2024 | 776,350.00 |
| Mar 31, 2024 | 702,150.00 |
| Mar 31, 2024 | 702,150.00 |
| Dec 31, 2023 | 330,000.00 |
| Dec 31, 2023 | 330,000.00 |